CS Paper Radar

Aptamers as a sandbox for lab-in-the-loop agentic molecular discovery

Zachary Cutts, John Coller, Rachel Chen, Hua Tang, Mathias Bellaiche, Ryder Easterlin, Dina Zverinski, Petar Sirkovic, Avinatan Hassidim, Yossi Matias, Pooja Rao, Annalisa Pawlosky

cs.AI q-bio.BMq-bio.QM ·submitted 2026-10-17 18:21 UTC · v1
hot direction

Abstract

Despite breakthroughs in AI-driven molecular generation, existing discovery pipelines operate largely in silico, with wet-lab feedback reserved for validation rather than iterative improvement. Whether large language model (LLM)-based reasoning agents can accelerate de novo discovery by iterating with lab data remains unproven. Here we use protein-binding aptamer design as a sandbox (1-2 week cycles, \$1-\$3 per candidate) to demonstrate a wet lab in a closed loop with AI systems. We tasked agentic pipelines with developing aptamer binders against $α$-thrombin and myoglobin across three design-test-improve cycles ($\sim$1,000 candidates per round; $\sim$4,400 constructs). Statistically significant, bead-corrected on-target hit rates among new candidates rose across rounds from 0.0% in Round 1 to 26.0% in Round 2 and 42.1% in Round 3 on $α$-thrombin (37.1% excluding literature motif descendants), and from 10.2% in Round 1 to 3.7% in Round 2 and 33.5% in Round 3 on myoglobin. Single-clone bead-binding titrations of eight full-length $α$-thrombin candidates confirmed concordance with pooled sequencing enrichment (Pearson $r = 0.90$). In these assays, literature-derived motifs engineered by the agents to reduce off-target reactivity in the pooled screen reached apparent affinities of $K_D = 24.6$--$133$ nM, whereas de novo scaffolds showed low-micromolar binding ($K_D > 1\ μ$M). We also report how our pipelines used myoglobin binding data to exploit the G-quadruplex binder space, diagnose cross-reactivity as on-target specificity dropped from 75.0% to 19.1%, and recover by developing strategies that restored specificity to 72.4%. We demonstrate that empirical lab data is more valuable than existing computational proxies, showing how iterative experimental feedback enables AI agents to diagnose assay artifacts and refine molecular designs across rounds.

Comment
Equal leadership (co-senior authors): Pooja Rao and Annalisa Pawlosky. 34 pages, 4 main figures, 1 main table, 3 supplementary figures, 4 supplementary tables

Closest papers

Nearest neighbours by meaning across the whole index.

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

cs.AI cs.CYq-bio.QM ·2026-09-05 ·Bryce Cai, Geetha Jeyapragasan, Samira Nedungadi, Jake Yukich, Seth Donoughe
publishedbenchmarkhighly cited similarity 0.68
Abstract · Last revised in February 2026; presented without further revision. An earlier revision at was presented at the NeurIPS 2025 Workshop on Bios…

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

0.57

Federation Is Nearly Free, Reasoning Is Not: Tradeoffs for AI Co-Scientists in Protein Characterization Workflows

cs.AI cs.MAq-bio.QM ·2026-08-25 ·Maia Kapur, Timothy Boe, Abby Jerger, Paul Rigor
similarity 0.66
Abstract · 24 Pages, 4 main figures, 5 main tables, 2 supplementary figures

Natural language driven autonomous co-scientist workflows involve a fundamental trade-off between flexibility and reasoning at the expense of determinism, reproducibility, and observability. Such agents increasingly must communicate across institutional boundaries, where federation topology can shape latency and cost. We systematically evaluated these tradeoffs using a controlled ablation on a production agentic platform for science. We use a verifiable task: given a protein sequence, we ask an agent to confidently characterize its function by routing across common tools. We compare federation topology, classic RL vs LLM-driven harnesses, language model, and prompt expertise. We also stratify results by protein novelty. We find that the choice of LLM dominated prediction quality far more than topology or prompting (Opus ~92%-94% vs o4-mini ~40%-50%). The PPO policy was nearly as accurate as the best LLM (88%) at zero token cost, fastest latency, and perfect consistency, but yields no reasoning trace. Expert prompted LLMs reached the highest accuracy but were high-cost and less consistent; prompt dependence was largest when the task was hardest. Federation imposed a negligible penalty on performance. These results offer actionable guidance for deploying agents for scientific workflows: for routine, verifiable tasks, a cheap deterministic policy delivers near-frontier accuracy with complete reproducibility, while flexible LLM reasoning is best reserved for open-ended discovery.

0.33

Explore or Confirm? LLM Agents Misallocate Measurements Under Noise

cs.AI cs.MA ·2026-10-18 ·Abdul Karim, Matt Keon
benchmarkcode/data similarity 0.65
Abstract · 38 pages, 12 figures. Code, data and environment: https://github.com/Xstendyl/wellocate

As model reasoning gets cheaper, the physical experiment becomes the slow and costly step in discovery. Each experiment returns a noisy reading: a high value can mean a good candidate or a lucky draw. With a fixed budget, an AI agent must keep choosing between exploring a new candidate and confirming a promising one by re-testing it. We measure that choice in Wellocate, a simulated assay campaign with known true values. It is built on a generated landscape and on two real protein datasets, GB1 and PhoQ, scrambled so no model can answer from memory. We test five language models as minimal agents, with no tools and no memory beyond the history in each prompt. They misallocate in both directions. Three over-confirm, spending most of the budget re-testing. On the generated landscape one under-confirms, trusting single readings, and there every model ends with a worse final pick than a basic scripted strategy. Each failure has its own cause. The over-confirmers run short of new candidates worth trying: a list of untried candidates cuts their re-testing and, on real protein data, makes two of them pick much better. A running summary of their readings or a description of the landscape changes it by at most five percentage points. For the under-confirmer, re-testing its top candidates in a final round, replayed on its own campaigns, recovers only about a quarter of what it loses by picking the wrong candidate. This suggests confirmation has to run through the whole campaign. We release Wellocate as a benchmark and reinforcement-learning environment with frozen splits and scripted baselines. With it, anyone can measure how an agent splits its budget before trusting it with real experiments, and train agents to split it better. Code, data and the environment are available at https://github.com/Xstendyl/wellocate.

0.41

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

cs.AI ·2026-10-29 ·Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim +13 more
community pick similarity 0.65
Abstract · v2: updated the author list

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

0.39

El Agente Fármaco: A Scalable AI Scientist for Drug Discovery

cs.AI cs.MAq-bio.BM ·2026-11-02 ·Marcel Müller, Mohammad Ghazi Vakili, Yoshihiro Ogura, Ella Ashoori, Shimeng Wang +11 more
benchmark similarity 0.65
Abstract · 63 pages, 13 figures, including Supporting Information

Computational drug discovery offers a growing range of tools for proposing and evaluating molecules, but combining them and deciding what to do next still requires substantial expert effort. Here, we introduce El Agente Fármaco, an AI scientist that uses modern large language model (LLM) technology to turn discovery goals expressed in everyday language into complex, scalable computational screening workflows. The agentic harness selects scientific tools, reviews their results, and adjusts subsequent steps to the target and the user's objectives. Our approach centers on a shared scientific memory: Fármaco Atlas, which stores molecules, structures, and results together with their provenance -- a record of how they were obtained. The agent uses targeted database queries to retrieve the evidence needed for each decision. A single request can launch calculations for an entire collection of molecules, without requiring a separate LLM decision for every compound. This design limits the information the model must process as screening collections grow, while keeping the underlying results available for inspection and further analysis. The integrated tools support molecule generation, prediction of binding and molecular properties, and searches for compounds available for purchase. In a retrospective comparison with an expert-led campaign, the agent proposed chemically distinct candidates with competitive docking scores and higher calculated drug-likeness under explicitly imposed selection criteria. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, with lower median cumulative token use and peak context. Fármaco provides a foundation for flexible, scalable drug discovery workflows that connect scientific reasoning with an enduring, traceable record of computational work.

0.08

AgentFold: Closed-Loop Agentic Search for Protein Folding Model Design

cs.AI ·2026-08-27 ·Mingquan Liu, Jiangyu Chen, Hanqun Cao, Xujun Zhang, Pengsen Ma +7 more
top venuecode/data similarity 0.64
Abstract

Scientific LLM agents have shown promise in literature reasoning, tool use, and experiment planning, but it remains unclear whether they can autonomously improve large, tightly coupled scientific machine-learning systems through executable code changes and computationally expensive validation. We study this question in protein folding, where progress requires coordinated architectural modifications, multi-objective evaluation, and domain-aware interpretation. We present AgentFold, a multi-agent framework that formulates folding-model development as a closed-loop search over executable code variants. Starting from ESMFold, AgentFold proposes hypotheses, implements and debugs code-level modifications, evaluates model variants, analyzes experimental outcomes, and stores both successful and failed interventions in structured memory. An MCTS-style policy allocates computational resources across high-scoring search branches. On an engineering-scale protein-folding codebase comprising more than 2,000 lines of code, AgentFold explores approximately 80 model variants using approximately 5,000 GPU-hours and 170 million LLM tokens. Under a matched computational budget, AgentFold improves the best lDDT by 7.5% over independent Codex proposals and outperforms a random-search control. Beyond model improvement, the resulting intervention traces reveal recurring empirical design patterns: stable gains tend to arise from early, soft, learnable priors and gated refinement, whereas direct geometric perturbations and geometry-conditioned feedback often destabilize training. The code and experimental resources are publicly available at https://github.com/lmqfly/AgentFold.

0.51

ReproBAIT: Can coding agents build their own biological AI tools?

cs.AI cs.CYcs.LG ·2026-10-14 ·Shiv Muthupandiyan, Tolga H. Dur, Mac Walker, Timo Flesch, Mahmoud Ghanem +6 more
code/data similarity 0.64
Abstract

Large language models are increasingly competent at leveraging scientific knowledge and existing computational tools to execute complex workflows. At present, little information exists on their ability to reconstruct tools when given limited descriptions of such tools. We introduce an evaluation titled ReproBAIT (Reproducing Biological AI Tools), which measures the ability of coding agents to design, implement, and train biological AI tools taken from published research across a range of information access conditions. The coding agent is securely sandboxed without internet access and receives training data, a fixed time and compute budget, and limited information about the tool to replicate. We then score the reproduced biological AI tool based on its performance (tool-specific metrics) on held-out data. We evaluated a set of biological AI tools of varying complexities: ProteinMPNN, an inverse protein folding tool, RFdiffusion3, an all-atom generative diffusion tool, and a closed-source molecular design tool. We institute a methodology to check for memorisation, as the open source tools are likely to be included in models' pretraining corpus. Across a range of leading closed- and open-source coding agents, we find substantial reproduction capability for some selected tools, though limited capability for a highly complex tool. We find moderate evidence consistent with memorisation, varying across coding agents. These results suggest that tool developers need to be increasingly cautious when releasing information about the tools publicly; re-creation of the tool based on such information could undermine a tool's commercial value or invalidate dual-use managed access strategies.

0.47

Tool-Augmented On-Policy Distillation for LLM Domain Adaptation in Sequence-Based Omics Tasks

cs.LG cs.CL ·2026-09-20 ·Jie Ying, Zhefan Wang, Zihong Chen, Zhengqing Li, Jinzhe Li +9 more
benchmark similarity 0.63
Abstract · 18 pages, 5 figures

Multi-omics sequences contain complex biological patterns, yet deciphering their mechanisms for automated scientific discovery remains challenging. As large language models (LLMs) interpret these sequences, evaluating both predictions and scientific reasoning is critical. However, existing benchmarks for multi-omics sequence tasks rely on classification and regression metrics, neglecting whether models grasp the underlying biological evidence. We introduce OmicsBench, the first reasoning benchmark for multi-omics sequences, comprising 1,160 expert-validated questions across six tasks spanning DNA regulation, RNA processing, and protein function. OmicsBench requires traceable evidence chains, evaluated using instance-specific rubrics developed with domain experts. Evaluating 17 LLMs reveals an inverse relationship: while scientific LLMs outperform general-purpose LLMs in sequence classification accuracy, they fail to provide valid evidence to support their predictions. One plausible interpretation is shortcut learning: specialized models may rely on statistical patterns rather than the biological mechanisms needed for scientific discovery. Motivated by this finding, we introduce tool-augmented on-policy distillation (TA-OPD), a post-training method to align sequence prediction with evidence-grounded biological reasoning. Across five Qwen3.5 models spanning 0.8B to 27B parameters, TA-OPD consistently strengthens biological evidence grounding while improving predictive performance on most tasks. These gains persist across model scales, indicating that stronger sequence reasoning does not arise solely from increased model capacity, but can be improved through evidence-aware training. Together, OmicsBench and TA-OPD provide a framework for diagnosing reasoning failures in multi-omics LLMs and a path toward models whose predictions are better grounded in biologically meaningful evidence.

0.14